The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000492358
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
17/03/2026
Date registered
Help: Date registered
21/04/2026
Date last updated
Help: Date last updated
24/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
21/04/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title

A feasibility study of group dysphagia therapy for head and neck cancer patients.
Scientific title
A feasibility study of group dysphagia therapy for head and neck cancer patients.
Additional trial identifiers [1] 316786 0
None
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Dysphagia 341110 0
Head and Neck Cancer 341111 0
Condition category
Condition code
Cancer 337225 337225 0 0
Head and neck
Musculoskeletal 337327 337327 0 0
Other muscular and skeletal disorders
Physical Medicine / Rehabilitation 337328 337328 0 0
Speech therapy
Oral and Gastrointestinal 337331 337331 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
An intensive group-based swallow therapy program supervised by a speech pathologist. The There will be 6 participants to each group and the session will be carried out face-to-face at Chris O'Brien Lifehouse, The groups will be held weekly for 1 hour for a total of 9 weeks. In the 10th week, a focus group session will be held.

To monitor adherence to the intervention, attendance will be noted at each session.

Group dysphagia therapy outline:
- 10 minutes: group discussion, speech pathologists will prompt participants to reflect on what has gone well with swallowing over past week, what has been more challenging.
- 40 minutes: swallowing therapy based around intensive, bolus driven rehabilitation program derived from the principles of exercise physiology and neuroplasticity. Each participant will have an individualised therapy program according to their goals and swallowing capability, they will be supported to complete this by Speech Pathologists leading the group.

Intensity will be increased and decreased according to the McNeil Dysphagia Therapy hierarchy, this is based on the viscosity of food and drink. Participants will complete as many functional swallows as they are able to within 40 minutes, using their recommended textures. The textures will be selected according to the most challenging and safe texture (no laryngeal penetration or aspiration) identified on instrumental assessment and will be modified according to progress.

The individually tailored program will be designed by the speech pathologist in the month prior to the intervention starting using the data collected at the enrolment visit- including the instrumental swallow study (Swallowing will be comprehensively assessed before and after the program, either with videofluroscopy (x-ray based) or FEES (endoscopy)), goal setting and patient questionnaires.

Participants will be recommended 30 minutes of daily home practice according to their individualised therapy programme provided in the group therapy sessions and updated according to progress. Should participants experience any signs of aspiration during home practice e.g. shortness of breath, voice changes, coughing, throat clearing, they will be advised to revert to easier consistencies, if this does not resolve aspiration signs they will be advised to cease swallow therapy until review at the next session and contact the Speech Pathologist
Intervention code [1] 333479 0
Rehabilitation
Description of the comparator or control
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 344843 0
Feasibility of intensive group-based swallow therapy program - program adherence
Timepoint [1] 344843 0
This will be assessed at the completion of the 9 group sessions
Primary outcome [2] 344844 0
Feasibility of patient reported home practice
Timepoint [2] 344844 0
Collected at each weekly session for the 9 weeks
Secondary outcome [1] 459088 0
To evaluate the efficacy of this program for swallow rehabilitation
Timepoint [1] 459088 0
In the 1 month prior to attending group intervention, then again in the 1 month post intervention conclusion
Secondary outcome [2] 459492 0
To evaluate the safety of this program for swallow rehabilitation
Timepoint [2] 459492 0
In the 1 month prior to attending group intervention, then again in the 1 month post intervention conclusion

Eligibility
Key inclusion criteria
• greater than or equal to 6 months post completion of treatment for head and neck cancer
• Diagnosis of head and neck cancer which has been treated with surgery or radiotherapy +/- chemotherapy with curative intent.
• Presenting with persistent dysphagia, as assessed by treating speech pathologist to require modification of diet and/or fluids due to swallow function, or with EAT-10 score of less than or equal to 3.
• Clearance for intensive swallow rehabilitation by treating oncology/surgical team.
• >18 years of age.
• Willingness to provide informed consent and attend intensive swallow rehabilitation program.
Minimum age
19 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Patients who were unable to follow instructions in English or commit to a 9-week therapy programme.
• Patients who are deemed unsafe to consume any form of liquid/diet intake.
• Active head and neck cancer.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW

Funding & Sponsors
Funding source category [1] 321383 0
Hospital
Name [1] 321383 0
Chris O'Brien Lifehouse
Country [1] 321383 0
Australia
Primary sponsor type
Hospital
Name
Chris O'Brien Lifehouse
Address
Country
Australia
Secondary sponsor category [1] 324125 0
None
Name [1] 324125 0
Address [1] 324125 0
Country [1] 324125 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319924 0
Sydney Local Health District Ethics Review Committee (RPAH Zone)
Ethics committee address [1] 319924 0
Ethics committee country [1] 319924 0
Australia
Date submitted for ethics approval [1] 319924 0
19/11/2025
Approval date [1] 319924 0
30/01/2026
Ethics approval number [1] 319924 0
2025/ETH02673

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148834 0
Ms Briony Adshead
Address 148834 0
Chris O'Brien Lifehouse, 119-143 Missenden Rd, Camperdown NSW 2050
Country 148834 0
Australia
Phone 148834 0
+61 2 8514 0972
Fax 148834 0
Email 148834 0
Contact person for public queries
Name 148835 0
Briony Adshead
Address 148835 0
Chris O'Brien Lifehouse, 119-143 Missenden Rd, Camperdown NSW 2050
Country 148835 0
Australia
Phone 148835 0
+61 2 8514 0972
Fax 148835 0
Email 148835 0
Contact person for scientific queries
Name 148836 0
Briony Adshead
Address 148836 0
Chris O'Brien Lifehouse, 119-143 Missenden Rd, Camperdown NSW 2050
Country 148836 0
Australia
Phone 148836 0
+61 2 8514 0972
Fax 148836 0
Email 148836 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.